Natalia Beglova, PhD
Beth Israel Deaconess Medical Center, Harvard Medical School, Boston
Many people with lupus suffer from blood clots. Also called “thromboses,” these clots inside blood vessels interfere with the flow of blood through the body and can cause serious complications. These dangerous clots are more common among people with lupus who have autoimmune antibodies to a particular protein: beta2-glycoprotein I (b2GPI).
With LRI funding, Dr. Beglova will test if a molecule that she has created effectively blocks the activity of this protein in a lupus mouse model.
If this exciting study does in fact uncover a way to interfere with a destructive role of b2GPI, it will open up a whole new avenue for creating medicines to counter damaging and sometimes life-threatening thromboses in lupus.
On the go?
Text INFO to 50555 and opt-in to receive breaking news about lupus on your mobile phone.
Message and Data Rates May Apply. Text STOP to 50555 to STOP. Text HELP to 50555 for HELP. Full Terms
- B Cells
- Cardiovascular System
- Cell Signaling
- Central Nervous System
- Dendritic Cells
- Environmental Triggers
- Gender Matters
- General Immune System Function
- Human Lupus Biology
- Lupus Pregnancy
- New to Lupus
- New Treatments
- T Cells
- Target Identification
- Why the Lupus Immune System Reacts to Its Own DNA